Vertex Pharmaceuticals vs Align Technology

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (71 vs 71)
Vertex Pharmaceuticals logo

Vertex Pharmaceuticals

LeaderHealthcare Tech

Enterprise

Vertex Pharmaceuticals (VRTX) reported $10.7B revenue in FY2024, up 12% YoY. Global leader in cystic fibrosis treatment. Near-monopoly on CF drugs. HQ: Boston, MA. Market cap ~$110B.

AI VisibilityBeta
Overall Score
B71
Category Rank
#140 of 290
AI Consensus
58%
Trend
stable
Per Platform
ChatGPT
79
Perplexity
76
Gemini
72

About

Vertex Pharmaceuticals Incorporated is a global biotechnology company and the world's undisputed leader in cystic fibrosis (CF) treatment, headquartered in Boston, Massachusetts. Founded in 1989 by Joshua Boger, Vertex pioneered the development of CFTR modulators — drugs that target the underlying cause of CF (a defective protein) rather than just managing symptoms. The company reported revenues of $10.7B in FY2024, up 12% year-over-year, with a near-monopoly on the CF treatment market.

Full profile
Align Technology logo

Align Technology

LeaderHealthcare Tech

Enterprise

San Jose clear aligner orthodontics inventor (NASDAQ: ALGN) at $3.23B 2024 revenue; 20 million Invisalign patient milestone Q1 2025 across 280,000+ doctors with iTero Lumina scanner competing with 3M Clarity for orthodontic clear aligner prescriptions.

AI VisibilityBeta
Overall Score
B71
Category Rank
#72 of 290
AI Consensus
69%
Trend
up
Per Platform
ChatGPT
77
Perplexity
66
Gemini
72

About

Align Technology, Inc. is a San Jose, California-based global medical device company — publicly traded on NASDAQ (NASDAQ: ALGN) as an S&P 500 component — operating as the inventor of the Invisalign System and the world leader in clear aligner orthodontics, reaching 20 million Invisalign patients treated worldwide in Q1 2025 through a network of 280,000+ Invisalign-trained doctors across 100+ countries. In fiscal year 2024, Align reported $3.23 billion in total revenue with Q4 2024 revenue of $995.2 million (+4.0% year-over-year). Align's product portfolio comprises the Invisalign System of clear aligners, iTero intraoral digital scanners (including the iTero Lumina with 3X wider field of capture in a 50% smaller wand), and exocad CAD/CAM software for digital dental workflows. Manufacturing is based in Mexico with treatment planning performed in Costa Rica. CEO Joseph Hogan joined from GE Healthcare in 2015. Founded 1997 by Zia Chishti and Kelsey Wirth in San Jose.

Full profile

AI Visibility Head-to-Head

71
Overall Score
71
#140
Category Rank
#72
58
AI Consensus
69
stable
Trend
up
79
ChatGPT
77
76
Perplexity
66
72
Gemini
72
65
Claude
64
63
Grok
69

Key Details

Category
Enterprise
Enterprise
Tier
Leader
Leader
Entity Type
company
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.